Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

A holistic or integrative approach to hair loss considers the hair growth cycle and hair loss from a nutritional, ...

Alten specialises in engineering and IT services and has a global presence in over 30 countries. The company describes itself as a “leading technological partner” for major industrial clients and has ...

Sumitomo Chemical Company, Limited ( OTCPK:SOMMY) Q3 2025 Results Conference Call February 3, 2025 3:00 AM ET Takato Watabe - Morgan Stanley MUFG Securities Makio Yamada - Mizuho Securities Go ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

We recently compiled a list of the 12 Best Dividend Stocks Under $30. In this article, we are going to take a look at where ...

Pfizer in a statement said it was pleased Do No Harm had decided to voluntarily dismiss the case, which the company said had no merit. The New York-based company changed the program's criteria in ...

In an interview on CNBC’s Mad Money, Dr. Albert Bourla said Pfizer (PFE) is focusing on business development to create shareholder value. “We ...

Finally, UBS Group lowered their price objective on shares of Pfizer from $31.00 to $29.00 and set a “neutral” rating for the company in a research report on Wednesday, January 8th.

Analysts expect Pfizer to post earnings of $0.48 per share and revenue of $17,264,454.90 billion for the quarter. Persons interested in participating in the company’s earnings conference call ...

Pfizer and GSK vaccines will now be required to carry warnings that they may be tied to an increased risk of a rare neurological side effect. © 2024 Fortune Media IP ...